Merlin Inc develops software that fulfills the functions of a human pilot in self-flying aircraft to enable both reduced crew and unmanned flight... Show more
Merlin, Inc. is an aerospace and defense technology company building what it describes as an operating system for autonomous flight. Its flagship product, the Merlin Pilot, is an AI-powered, aircraft-agnostic autonomy system designed to fly aircraft from takeoff to touchdown across both military and civil programs. The company pursues a full-stack approach, integrating software, safety systems, and certification workflows to enable uncrewed and optionally-crewed flight.
Merlin began trading on the Nasdaq under the MRLN symbol in March 2026 following the completion of its business combination with Inflection Point Acquisition Corp. IV, a special purpose acquisition company. The company has reported more than $100 million in total awarded contracts from military customers and has announced technical milestones including a critical design review for the U.S. Special Operations Command C-130J program and its first fully autonomous landing. Investors follow the stock for its exposure to defense autonomy, AI-driven aviation, and a long-term shift toward reduced-crew and uncrewed flight.
Over the last 30 days, MRLN has moved decisively lower. Using the closing price of $3.35 on September 4 as the starting reference point, the stock has fallen approximately 52.8% to around $1.58. The decline was not linear: shares traded near $3.05 in mid-September before a sharp, high-volume selloff pushed the price to $2.21 on September 16, a single-session drop of roughly 27%.
The 30-day move is part of a longer slide. Over the last quarter, MRLN has lost approximately 63%, declining from about $4.30 in early July to current levels. The stock briefly traded near $4.44 in early August before turning lower, meaning the weakness accelerated as quarterly earnings were digested and broader selling pressure mounted. The persistent one-way trend reflects a sustained re-rating of the shares rather than a single isolated event.
Several verified factors contributed to the recent decline. On August 13, Merlin reported second-quarter results that missed expectations: revenue of $2.19 million fell short of the roughly $3.85 million analysts anticipated, and the company posted an actual loss per share of -$1.40 against an estimated -$0.28. A GAAP net loss of $58.4 million and widening operating expenses highlighted continued cash burn as the company invests in platform development and certification. The earnings release marked the start of a sustained down-leg in the shares.
Selling intensified in mid-September, when MRLN fell from $3.05 on September 15 to $2.21 the following day on volume of roughly 7.6 million shares, far above its typical daily turnover. The move coincided with renewed concerns about dilution. In April, Merlin announced an $80 million PIPE financing that included 8 million new shares and warrants to purchase 4 million additional shares, expanding the share count and creating a potential overhang as registered shares became eligible for resale.
Notably, the selling continued even as analysts reaffirmed constructive views. Maxim Group initiated coverage with a Buy rating on September 18, and firms including Northland Securities, Cantor Fitzgerald, and TD Cowen maintained Buy ratings with price targets ranging from $7 to $10. The gap between analyst targets and the trading price underscores how execution risk, liquidity, and dilution concerns have outweighed fundamental optimism in the short term.
The quarterly trend reflects a broader re-rating of a newly public, pre-profit company operating in a capital-intensive sector. Since listing in March, Merlin has reported growing operating losses while revenue remains modest relative to its valuation. The April PIPE strengthened the balance sheet but also diluted existing holders and introduced warrant-linked overhang. Second-quarter results showed revenue below consensus and a much wider net loss, reinforcing concerns about the pace at which contract awards and technical milestones will translate into meaningful sales.
At the same time, the company has continued to advance its technology roadmap, including the C-130J critical design review and an initial fully autonomous landing, alongside a partnership with Israel Aerospace Industries for AI-based autonomy on cargo aircraft. These achievements have not yet been enough to offset investor focus on near-term profitability, cash usage, and financing risk, which have driven the multi-month decline.
For investors seeking data-driven approaches to volatile stocks, Tickeron's Trending AI Robots page offers a curated view of its AI trading bots. Tickeron provides hundreds of AI-powered trading bots that monitor thousands of tickers, but only the top-performing and most relevant bots are surfaced in this section. These bots vary in strategy, timeframe, and performance metrics, allowing users to explore approaches suited to different market conditions and risk tolerances. The page is designed to help traders identify currently active, high-conviction signals without manual screening. Visitors can review the featured bots and their recent performance to see how algorithmic strategies are positioned across the market.
Looking ahead, investors will focus on whether Merlin can convert its contract pipeline and technical milestones into revenue. Management has guided to $4 million to $6 million in revenue for the second half of 2026, and progress against that range will be a key test. Execution on the USSOCOM C-130J program, advancement of regulatory certification, and expansion of the Israel Aerospace Industries partnership are among the most important operational catalysts.
Financial durability also remains central. Merlin reported roughly $183.9 million in cash, cash equivalents, and short-term investments as of June 30, but elevated R&D and general spending will keep cash burn in focus. The potential for additional share issuance or warrant-related activity remains a risk to existing holders. Finally, broader sentiment toward early-stage, pre-profit aerospace and AI names, defense spending trends, and analyst revisions to estimates will continue to influence the stock's direction.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for MRLN just turned positive on October 13, 2026. Looking at past instances where MRLN's MACD turned positive, the stock continued to rise in 6 of 15 cases over the following month. The odds of a continued upward trend are 40%.
Following a +7.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRLN advanced for three days, in 31 of 78 cases, the price rose further within the following month. The odds of a continued upward trend are 40%.
MRLN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on September 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MRLN as a result. In 11 of 35 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 31%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRLN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
The Aroon Indicator for MRLN entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.991) is normal, around the industry mean (4.905). P/E Ratio (0.308) is within average values for comparable stocks, (16.553). Projected Growth (PEG Ratio) (0.090) is also within normal values, averaging (2.564). Dividend Yield (0.024) settles around the average of (0.062) among similar stocks. P/S Ratio (23.148) is also within normal values, averaging (18.330).
The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. MRLN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRLN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of equipment leasing solutions to small businesses
Industry AerospaceDefense